Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-03 Purchase | 2019-09-03 7:34 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 500 | $86.18 | $43,091 | 17,151 (Direct) | View |
| 2018-08-29 Sale | 2018-08-29 8:35 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 18,357 | $256.69 | $4,712,060 | 13,666 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-23 Option Award | 2023-02-27 8:52 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 33,697 | $0 | 123,376 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 2,890 | $72.98 | 89,679 (Direct) | View |
| 2022-12-28 Tax Withholding | 2022-12-30 5:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 3,859 | $66.29 | 92,569 (Direct) | View |
| 2022-12-22 Option Award | 2022-12-27 6:34 pm | N/A 2032-12-22 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 25,967 | $0 | 25,967 (Direct) | View |
| 2022-12-13 Option Award | 2022-12-15 6:17 pm | N/A 2032-12-13 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 44,000 | $0 | 126,428 (Direct) | View |
| 2022-11-30 Tax Withholding | 2022-12-01 9:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 3,593 | $72.9 | 82,428 (Direct) | View |
| 2022-11-01 Option Award | 2022-11-03 9:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO | 27,714 | $0 | 86,021 (Direct) | View |
| 2022-07-11 Option Award | 2022-08-04 4:16 pm | N/A 2032-07-11 | Qualigen Therapeutics Inc. | QLGN | Korenberg Matthew E Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-30 Other | 2022-07-06 8:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 164 | $75.84 | 52,696 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 5:54 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 8,062 | $0 | 52,368 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 8:10 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 30,189 | $0 | 30,189 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-16 8:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 3,407 | $123.68 | 44,306 (Direct) | View |
| 2022-01-26 Tax Withholding | 2022-01-28 8:43 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 3,628 | $113.68 | 47,713 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 8:43 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 11,651 | $0 | 47,713 (Direct) | View |
| 2021-06-30 Other | 2021-07-02 5:13 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 247 | $85.91 | 39,937 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 2,309 | $172.46 | 39,443 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:02 pm | N/A 2031-02-03 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 22,410 | $0 | 53,343 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 2,111 | $156.01 | 30,933 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 7,108 | $0 | 30,933 (Direct) | View |
| 2020-06-30 Other | 2020-07-01 8:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 238 | $89.03 | 26,174 (Direct) | View |
| 2020-06-06 Option Award | 2020-06-08 9:22 pm | N/A 2030-06-06 | Qualigen Therapeutics Inc. | QLGN | Korenberg Matthew E Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 1,166 | $120.86 | 15,303 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:05 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 37,598 | $0 | 57,614 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 2,114 | $105.87 | 20,016 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 4,979 | $0 | 20,016 (Direct) | View |
| 2019-06-28 Other | 2019-07-02 9:49 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 182 | $97.03 | 16,833 (Direct) | View |
| 2019-02-11 Option Award | 2019-02-13 4:35 pm | N/A 2029-03-02 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 35,702 | $0 | 45,767 (Direct) | View |
| 2019-01-23 Tax Withholding | 2019-01-25 4:30 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 1,325 | $111.78 | 10,065 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 4:30 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 4,648 | $0 | 10,065 (Direct) | View |
| 2018-08-29 Exercise | 2018-08-29 8:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 11,540 | $85.79 | 13,666 (Direct) | View |
| 2018-08-29 Exercise | 2018-08-29 8:35 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 11,540 | $0 | 13,666 (Direct) | View |
| 2018-08-06 Tax Withholding | 2018-08-07 4:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 836 | $226.74 | 13,559 (Direct) | View |
| 2018-06-29 Other | 2018-07-03 3:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO | 180 | $117.84 | 14,575 (Direct) | View |